Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now

DENTSPLY SIRONA (XRAY) is well poised for growth on a robust product portfolio and continued focus on research and development. However, forex remains a concern.Shares of this Zacks Rank #3 (Hold) company have lost 9.4% year to date against the industry's 6.2% growth. The S&P 500 Index has gained 9.9% in the same time frame.XRAY, with a market capitalization of $6.88 billion, is a global leader in the design, development, manufacturing and marketing of dental consumables, dental laboratory products, dental ...